FIELD: pharmaceutics.
SUBSTANCE: proposed group of inventions relates to the pharmaceutical industry, namely to the use of a preparation for the treatment of elementoses in a subject. The use of a preparation of lateral shoots or leaves of Polyscias filicifolia plant, obtained by alcohol extraction of the plant or by a biotechnological method for plant cell culture, for the treatment of elementoses in a subject in need of it is proposed, where elementoses are induced by ingestion of an extraneous chemical compound to the organism of the subject deviations in the content in one or several internal organs of the subject of at least one essential element selected from a group: Ca, Cr, I, Mn, Cu, Mg, Fe, Zn without the need to use sources or chelators of essential elements, the content of which is violated. The use of a preparation of lateral shoots or leaves of Polyscias filicifolia plant, obtained by a biotechnological method for plant cell culture, for the treatment of elementoses in a subject in need of it is proposed, where elementoses are induced by ingestion of an extraneous chemical compound and/or an infectious disease to the organism of a subject deviations in the content in one or more internal organs of the subject of at least one essential element selected from a group: Ca, Cu, Mg, Fe, Zn without the need to use sources or chelators of essential elements, the content of which is violated.
EFFECT: above-described use of the preparation obtained from lateral shoots or leaves of Polyscias filicifolia plant is effective for the treatment of elementoses in the subject.
10 cl, 10 dwg, 4 tbl, 6 ex
Title |
Year |
Author |
Number |
METHOD OF LOW-TOXIC ALCOHOLIC DRINK MAKING |
1995 |
|
RU2066686C1 |
STRAIN OF CELL CULTURE POLYSCIAS FILICIFOLIA (MOORE EX ROUNIER) BAILEY FOR RECEIVING MEDICINAL PREPARATION, NUTRITIONAL SUPPLEMENTS AND COSMETICS |
2006 |
- Kotin Arkadij Mikhajlovich
|
RU2337138C2 |
COMPOSITION OWNING DISINTOXICATION PROPERTIES IN RESPECT OF TOXIC METAL Cd, Pb, Sn AND Al, AND METHOD OF APPLICATION OF THE INDICATED COMPOSITION |
2017 |
- Skalnyj Anatolij Viktorovich
- Tinkov Aleksej Alekseevich
|
RU2688684C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND APPLICATIONS THEREOF |
2017 |
- Colquhoun, Helen
- Kanes, Stephen, Jay
|
RU2766155C2 |
SPECIFIC PEPTIDE CLATHRIN INHIBITORS |
2017 |
- Kotin Arkadij Mikhajlovich
- Emelyanov Maksim Olegovich
- Kotin Oleg Arkadevich
|
RU2651491C1 |
TREATMENT OF ESSENTIAL TREMOR, USING (R)-2-(4-ISOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUORETHOXY)PYRIDINE-2-YL)ETHYL)ACETAMIDE |
2019 |
- Lee, Margaret S.
- Papapetropoulous, Spyridon
- Higgin, Michelle S.
- Duvvuri, Muralikrishna
- Rehlaender, Bruce N.
- Newbold, Evan
|
RU2780318C1 |
MEDICAL AGENTS DELIVERY TO THE CENTRAL NERVOUS SYSTEM |
2011 |
- Kalias Perikls
- Pan Tszin
- Pauvell Dzhen
- Charnas Lourens
- Makkoli Tomas
- Rajt Teresa Leakh
- Pfajfer Richard
- Shakhrokkh Zakhra
|
RU2626514C2 |
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3, IN COMBINATION WITH COSTIMULATION 4-1BB |
2020 |
- Kirshner, Dzhessika R.
- Krouford, Elison
- Chiu, Danika
|
RU2822091C2 |
COMPOSITIONS CAUSING SPECIFIC RESPONSE OF CYTOTOXIC T-LYMPHOCYTES, INCLUDING LYMPH-ABLATIVE COMPOUND AND MOLECULE WHICH CONTAINS ANTIGEN SEQUENCES AND IS TARGETED AT SPECIALISED ANTIGEN-PRESENTING CELLS |
2007 |
- Previll' Ksav'E
- Timmerman Benedikt
|
RU2448729C2 |
AGENT FOR DISEASE TREATMENT |
2009 |
- Ajgner Zil'Ke
- Germer Mattias
- Osterrot Frank
- Uehrek Kristof
- Kraus Ehl'Mar
- Vartenberg-Demand Andrea
- Vol'F Daniehle
- Kajzer Zibille
- Lindner Jurgen
- Brjukher Kristof
- Delken Benzhamin
|
RU2540018C2 |